Hengrui Pharma Gets Nod for Injectable Cancer Drug Trial-- Jiangsu Hengrui Pharmaceuticals has been approved by China's National Medical Products Administration to conduct clinical trials on a new injectable cancer drug, SHR-7631, according to a filing...